Extraction-Free Pathogen Testing With Direct PCR Buffer Chemistry
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for infectious diseases, such as PCR, require an initial step of nucleic acid isolation and purification, which is laborious, expensive, and prone to contamination and human error.
Innovation Solution
The development of compositions and methods for extraction-free detection and analysis of nucleic acid in biological samples, using a unique buffer composition that prepares nucleic acid for direct amplification and analysis without the need for initial extraction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If nucleic acid isolation and purification is performed using conventional extraction methods, then the quality and purity of nucleic acid for PCR detection is improved, but the complexity of the diagnostic process, time required, and cost increase significantly
Solution Approach 1:
The patent removes the nucleic acid extraction step entirely from the diagnostic workflow. Instead of isolating and purifying nucleic acid through complex extraction protocols, the invention uses a buffer-based system that allows direct PCR amplification from clinical samples, eliminating the extraction bottleneck while maintaining detection reliability
Solution Approach 2:
The buffer composition serves multiple functions simultaneously: it acts as a transport medium for clinical samples, maintains nucleic acid stability during storage and transport, and enables direct PCR amplification without extraction. This multi-functional buffer replaces multiple separate reagents and steps in conventional workflows
2Reliability
If manual nucleic acid extraction steps are performed, then nucleic acid purity is improved, but labor costs and time consumption increase
Solution Approach 1:
The buffer system is designed to work autonomously with clinical samples without requiring manual extraction operations. The buffer itself provides the necessary conditions for nucleic acid stability and direct PCR amplification, making the system self-sufficient and eliminating dependency on labor-intensive extraction procedures
3Stability of the object's composition
If viral transport media are used to preserve samples, then sample stability during transport is improved, but PCR amplification is inhibited
Solution Approach 1:
The invention changes the chemical parameters of the transport medium by using a buffer composition with specific pH and ionic strength that is compatible with both sample stability and PCR amplification. This buffer formulation eliminates the inhibitory substances present in conventional viral transport media while maintaining nucleic acid integrity during transport and storage
Data Source
AI summary
The invention provides compositions and methods allowing for rapid, accurate, robust, and low-cost diagnosis of infectious diseases via extraction-free, direct PCR techniques.